Cargando…

OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK/MAPK Pathway

Orthodenticlehomeobox 1 (OTX1) overexpression had previously been associated with the progression of several tumors. The present study aimed to determine the expression and role of OTX1 in human hepatocellular carcinoma (HCC). The expression level of OTX1 was examined by quantitative real-time PCR (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hua, Miao, Qian, Xu, Chun-wei, Huang, Jian-hui, Zhou, Yue-fen, Wu, Mei-juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951550/ https://www.ncbi.nlm.nih.gov/pubmed/27478331 http://dx.doi.org/10.3346/jkms.2016.31.8.1215

Ejemplares similares

MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma
por: Moon, Hyuk, et al.
Publicado: (2021)

GPR27 Regulates Hepatocellular Carcinoma Progression via MAPK/ERK Pathway
por: Wang, Hongxv, et al.
Publicado: (2022)

HLTF promotes hepatocellular carcinoma progression by enhancing SRSF1 stability and activating ERK/MAPK pathway
por: Xu, Yanan, et al.
Publicado: (2023)

NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway
por: Zhao, Jing, et al.
Publicado: (2017)

Long non-coding RNA Igf2as controls hepatocellular carcinoma progression through the ERK/MAPK signaling pathway
por: Bao, Han, et al.
Publicado: (2017)

MAPK-ERK Pathway
por: Park, Jong-In
Publicado: (2023)

STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway
por: Zhang, Chengfei, et al.
Publicado: (2021)

HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma
por: Wang, Wei-Min, et al.
Publicado: (2017)

Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway
por: Wang, Mu-Ru, et al.
Publicado: (2020)

OTX1 and OTX2 as Possible Molecular Markers of Sinonasal Carcinomas and Olfactory Neuroblastomas
por: Pirrone, Cristina, et al.
Publicado: (2017)

Cordycepin inhibits the proliferation and progression of NPC by targeting the MAPK/ERK and β-catenin pathways
por: Zhou, Yaqi, et al.
Publicado: (2022)

LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway
por: Zhang, Quan, et al.
Publicado: (2020)

OTX1 promotes tumorigenesis and progression of cervical cancer by regulating the Wnt signaling pathway
por: Zhou, Limin, et al.
Publicado: (2022)

Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway
por: Cubas, Rafael, et al.
Publicado: (2010)

Oncogenic role of mortalin contributes to ovarian tumorigenesis by activating the MAPK–ERK pathway
por: Hu, Yingying, et al.
Publicado: (2016)

ERK/MAPK signalling pathway and tumorigenesis
por: Guo, Yan-Jun, et al.
Publicado: (2020)

Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling
por: Wang, Ji-Long, et al.
Publicado: (2018)

Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression
por: Li, Qiang, et al.
Publicado: (2020)

HBV precore G1896A mutation promotes growth of hepatocellular carcinoma cells by activating ERK/MAPK pathway
por: Zhao, Baoxin, et al.
Publicado: (2023)

CMaf-Inducing Protein Promotes LUAD Proliferation and Metastasis by Activating the MAPK/ERK Pathway
por: Yu, Xiao-Yan, et al.
Publicado: (2022)

Long Non-coding RNA URHC Regulates Cell Proliferation and Apoptosis via ZAK through the ERK/MAPK Signaling Pathway in Hepatocellular Carcinoma
por: Xu, Wei-Hua, et al.
Publicado: (2014)

Dermokine mutations contribute to epithelial-mesenchymal transition and advanced melanoma through ERK/MAPK pathways
por: Ma, Wenqiong, et al.
Publicado: (2023)

Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways
por: Chen, Shi‐Lu, et al.
Publicado: (2019)

Human circular RNA hsa_circRNA_101705 (circTXNDC11) regulates renal cancer progression by regulating MAPK/ERK pathway
por: Yang, Chong-Yi, et al.
Publicado: (2021)

Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways
por: Yang, Liang, et al.
Publicado: (2020)

Photoreceptor cKO of OTX2 Enhances OTX2 Intercellular Transfer in the Retina and Causes Photophobia
por: Pensieri, Pasquale, et al.
Publicado: (2021)

Mindin serves as a tumour suppressor gene during colon cancer progression through MAPK/ERK signalling pathway in mice
por: Cheng, Xiao‐Shen, et al.
Publicado: (2020)

HIGD2A silencing impairs hepatocellular carcinoma growth via inhibiting mitochondrial function and the MAPK/ERK pathway
por: Huang, Kuiyuan, et al.
Publicado: (2023)

The Roles of PI3K/AKT/mTOR and MAPK/ERK Signaling Pathways in Human Pheochromocytomas
por: Du, Juan, et al.
Publicado: (2016)

miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling
por: Xiao, Shuai, et al.
Publicado: (2018)

Zebrafish Lbh-like Is Required for Otx2-mediated Photoreceptor Differentiation
por: Li, Wen-Hua, et al.
Publicado: (2015)

The ERK MAPK Pathway Is Essential for Skeletal Development and Homeostasis
por: Kim, Jung-Min, et al.
Publicado: (2019)

Downregulation of Talin1 promotes hepatocellular carcinoma progression through activation of the ERK1/2 pathway
por: Chen, Peijuan, et al.
Publicado: (2017)

Homeoprotein OTX1 and OTX2 involvement in rat myenteric neuron adaptation after DNBS-induced colitis
por: Bistoletti, Michela, et al.
Publicado: (2020)

PICALM exerts a role in promoting CRC progression through ERK/MAPK signaling pathway
por: Zhang, Xitao, et al.
Publicado: (2022)

CDCA8 induced by NF-YA promotes hepatocellular carcinoma progression by regulating the MEK/ERK pathway
por: Chen, Erbao, et al.
Publicado: (2023)

Up-Regulation of Urotensin II and Its Receptor Contributes to Human Hepatocellular Carcinoma Growth via Activation of the PKC, ERK1/2, and p38 MAPK Signaling Pathways
por: Yu, Xiao-Tong, et al.
Publicado: (2014)

Correction to: miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling
por: Xiao, Shuai, et al.
Publicado: (2021)

Orthodenticle Homeobox OTX1 Promotes Papillary Thyroid Carcinoma Progression and Is a Potential Prognostic Biomarker
por: Wei, Jing, et al.
Publicado: (2023)

TFF3 Contributes to Epithelial-Mesenchymal Transition (EMT) in Papillary Thyroid Carcinoma Cells via the MAPK/ERK Signaling Pathway
por: Lin, Xu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a17754v423g3q9r0jjl3524i1b